Free Trial
CVE:VIV

Avivagen (VIV) Stock Price, News & Analysis

Avivagen logo
C$0.0050 0.00 (0.00%)
As of 03/5/2024

About Avivagen Stock (CVE:VIV)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.08
Volume
2,820 shs
Average Volume
49,827 shs
Market Capitalization
C$388,450.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

Remove Ads
Receive VIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

VIV Stock News Headlines

Avivagen Inc (VIV)
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Pure Harvest Corporate Group, Inc. (PHCG)
Closing Bell: Avivagen Inc flat on Monday (VIV)
Avivagen Announces New 500Kg Order for OxC-beta™
See More Headlines

VIV Stock Analysis - Frequently Asked Questions

Avivagen's stock was trading at C$0.01 at the start of the year. Since then, VIV shares have increased by 0.0% and is now trading at C$0.01.
View the best growth stocks for 2025 here
.

Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avivagen investors own include AtkinsRéalis (SNCAF) and ProMetic Life Sciences (PLI).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Communication
Current Symbol
CVE:VIV
CIK
N/A
Fax
N/A
Employees
34,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-4,640,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$403,780.00
Cash Flow
C$0.00 per share
Price / Cash Flow
12.14
Book Value
C($0.12) per share
Price / Book
-0.04

Miscellaneous

Free Float
N/A
Market Cap
C$388,450.00
Optionable
Not Optionable
Beta
1.06
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:VIV) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners